• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中成像与循环生物标志物的整合:欧洲心脏病学会心力衰竭协会生物标志物与成像研究组的共识文件

Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology.

作者信息

Moura Brenda, Aimo Alberto, Al-Mohammad Abdallah, Flammer Andreas, Barberis Vassilis, Bayes-Genis Antoni, Brunner-La Rocca Hans-Peter, Fontes-Carvalho Ricardo, Grapsa Julia, Hülsmann Martin, Ibrahim Nasrien, Knackstedt Christian, Januzzi James L, Lapinskas Tomas, Sarrias Axel, Matskeplishvili Simon, Meijers Wouter C, Messroghli Daniel, Mueller Christian, Pavo Noemi, Simonavičius Justas, Teske Arco J, van Kimmenade Roland, Seferovic Petar, Coats Andrew J S, Emdin Michele, Richards A Mark

机构信息

Faculty of Medicine, University of Porto, Porto, Portugal.

Cardiology Department, Porto Armed Forces Hospital, Porto, Portugal.

出版信息

Eur J Heart Fail. 2021 Oct;23(10):1577-1596. doi: 10.1002/ejhf.2339. Epub 2021 Sep 14.

DOI:10.1002/ejhf.2339
PMID:34482622
Abstract

Circulating biomarkers and imaging techniques provide independent and complementary information to guide management of heart failure (HF). This consensus document by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) presents current evidence-based indications relevant to integration of imaging techniques and biomarkers in HF. The document first focuses on application of circulating biomarkers together with imaging findings, in the broad domains of screening, diagnosis, risk stratification, guidance of treatment and monitoring, and then discusses specific challenging settings. In each section we crystallize clinically relevant recommendations and identify directions for future research. The target readership of this document includes cardiologists, internal medicine specialists and other clinicians dealing with HF patients.

摘要

循环生物标志物和成像技术为指导心力衰竭(HF)的管理提供了独立且互补的信息。欧洲心脏病学会(ESC)心力衰竭协会(HFA)的这份共识文件介绍了与HF中成像技术和生物标志物整合相关的当前循证指征。该文件首先关注循环生物标志物与成像结果在筛查、诊断、风险分层、治疗指导和监测等广泛领域的联合应用,然后讨论了特定的具有挑战性的情况。在每个部分中,我们梳理出临床相关建议并确定未来研究方向。本文档的目标读者包括心脏病专家、内科专家和其他治疗HF患者的临床医生。

相似文献

1
Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology.心力衰竭中成像与循环生物标志物的整合:欧洲心脏病学会心力衰竭协会生物标志物与成像研究组的共识文件
Eur J Heart Fail. 2021 Oct;23(10):1577-1596. doi: 10.1002/ejhf.2339. Epub 2021 Sep 14.
2
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.2019 年心力衰竭临床实践更新:药物治疗、程序、设备和患者管理。欧洲心脏病学会心力衰竭协会专家共识会议报告。
Eur J Heart Fail. 2019 Oct;21(10):1169-1186. doi: 10.1002/ejhf.1531. Epub 2019 Aug 30.
3
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).心力衰竭患者植入式装置治疗的整合。欧洲心脏病学会(ESC)心力衰竭协会(HFA)和欧洲心律协会(EHRA)的临床共识声明。
Eur J Heart Fail. 2024 Feb;26(2):483-501. doi: 10.1002/ejhf.3150. Epub 2024 Jan 25.
4
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups.欧洲心脏病学会成员国心力衰竭管理组织:欧洲心脏病学会心力衰竭协会与心力衰竭国家学会/工作组合作调查。
Eur J Heart Fail. 2013 Sep;15(9):947-59. doi: 10.1093/eurjhf/hft092. Epub 2013 Jun 19.
5
Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: design and accreditation document.欧洲心脏病学会心力衰竭协会护理质量中心项目:设计与认证文件
Eur J Heart Fail. 2020 May;22(5):763-774. doi: 10.1002/ejhf.1784. Epub 2020 Mar 18.
6
The Heart Failure Association Atlas: rationale, objectives, and methods.心力衰竭协会图谱:原理、目标和方法。
Eur J Heart Fail. 2020 Apr;22(4):638-645. doi: 10.1002/ejhf.1768. Epub 2020 Mar 3.
7
Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).急性心力衰竭的综合院内监测:临床实践的应用及研究的未来方向。欧洲心脏病学会心力衰竭协会(ESC)急性心力衰竭委员会的声明。
Eur J Heart Fail. 2018 Jul;20(7):1081-1099. doi: 10.1002/ejhf.1204. Epub 2018 Apr 30.
8
Consensus document of the management of type 2 diabetes and heart failure: Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH) and Inter-American Society of Cardiology (IASC).2 型糖尿病与心力衰竭管理共识文件:心脏衰竭和肺动脉高压的泛美理事会(CIFACAH)和美国心脏病学会(IASC)。
Arch Cardiol Mex. 2023;93(Supl):14-26. doi: 10.24875/ACM.23000059.
9
HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association.心血管植入式电子设备(CIEDs)监测的HRS/EHRA专家共识:技术、适应症、人员、频率及伦理考量的描述:与心律协会(HRS)和欧洲心律协会(EHRA)合作制定;并与美国心脏病学会(ACC)、美国心脏协会(AHA)、欧洲心脏病学会(ESC)、欧洲心脏病学会心力衰竭协会(HFA)及美国心力衰竭学会(HFSA)协作。得到心律协会、欧洲心律协会(ESC注册分支)、美国心脏病学会、美国心脏协会认可。
Europace. 2008 Jun;10(6):707-25. doi: 10.1093/europace/eun122. Epub 2008 May 14.
10
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society.糖尿病患者心力衰竭诊断的生物标志物:糖尿病技术协会共识报告
Prog Cardiovasc Dis. 2023 Jul-Aug;79:65-79. doi: 10.1016/j.pcad.2023.05.002. Epub 2023 May 11.

引用本文的文献

1
Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population.心力衰竭筛查:在普通人群中检测风险升高的生物标志物。
Curr Heart Fail Rep. 2024 Dec;21(6):591-603. doi: 10.1007/s11897-024-00686-6. Epub 2024 Sep 17.
2
Volume markers in left ventricular diastolic dysfunction and adverse outcomes in peritoneal dialysis patients: a prospective cohort study.左心室舒张功能障碍和腹膜透析患者不良结局的容量标志物:一项前瞻性队列研究。
Sci Rep. 2023 Oct 6;13(1):16892. doi: 10.1038/s41598-023-43442-x.
3
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy.
使用超声心动图和利钠肽进行患者表型分析以实现心力衰竭治疗个体化。
Heart Fail Rev. 2024 Mar;29(2):367-378. doi: 10.1007/s10741-023-10340-3. Epub 2023 Sep 20.
4
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study.可溶性ST2在轻链型和转甲状腺素蛋白型心脏淀粉样变中的预后价值:一项多中心研究
Front Cardiovasc Med. 2023 Aug 2;10:1179968. doi: 10.3389/fcvm.2023.1179968. eCollection 2023.
5
The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction.充血生物标志物在射血分数降低的心力衰竭中的作用
J Clin Med. 2023 Jun 3;12(11):3834. doi: 10.3390/jcm12113834.
6
Heart failure: an update from the last years and a look at the near future.心力衰竭:近年来的最新进展及对近期前景的展望。
ESC Heart Fail. 2022 Dec;9(6):3667-3693. doi: 10.1002/ehf2.14257.
7
Metabolomics implicate eicosanoids in severe functional mitral regurgitation.代谢组学提示类二十烷酸在严重功能性二尖瓣反流中的作用。
ESC Heart Fail. 2023 Feb;10(1):311-321. doi: 10.1002/ehf2.14160. Epub 2022 Oct 10.
8
Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis.射血分数保留的心力衰竭患者血浆半乳糖凝集素-3的临床意义:一项荟萃分析
Front Cardiovasc Med. 2022 Apr 14;9:854501. doi: 10.3389/fcvm.2022.854501. eCollection 2022.
9
Non-Invasive Assessment of Congestion by Cardiovascular and Pulmonary Ultrasound and Biomarkers in Heart Failure.心力衰竭中通过心血管和肺部超声及生物标志物对充血进行无创评估
Diagnostics (Basel). 2022 Apr 12;12(4):962. doi: 10.3390/diagnostics12040962.
10
Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity?当前的心力衰竭诊断和治疗指南是否适用于临床复杂性?
J Clin Med. 2022 Feb 6;11(3):857. doi: 10.3390/jcm11030857.